The race against time in stroke care has a new ally. West Virginia University (WVU) Health System has fully deployed Brainomix 360 Stroke, an AI-powered imaging platform, across all 25 of its hospital sites. This marks a significant step toward equitable access to rapid, accurate stroke diagnosis and treatment, particularly in a state where geographic barriers often complicate timely care. The implementation, announced on March 11, 2026, promises to standardize stroke assessment and accelerate critical decision-making for patients experiencing this life-threatening condition.
Stroke is a leading cause of long-term disability and the fifth leading cause of death in the United States, according to the Centers for Disease Control and Prevention (CDC). Every 40 seconds, someone in the U.S. Suffers a stroke, and prompt treatment is crucial to minimize brain damage and improve outcomes. The challenge, however, lies in the speed and accuracy of diagnosis, especially in rural and underserved areas where access to specialized neurological expertise is limited. Brainomix 360 Stroke aims to bridge this gap by providing clinicians with real-time, objective insights derived from medical imaging.
Developed as a spin-out from the University of Oxford, Brainomix has been gaining traction in the medical technology landscape. The company specializes in AI-powered imaging tools for both stroke and lung fibrosis. The 360 Stroke platform analyzes a range of imaging modalities – including CT, CTA, CTP, and MRI – to quickly identify critical indicators of stroke, such as large-vessel occlusions (LVOs) and the extent of ischemic core volume. This information is vital for determining the most appropriate treatment strategy, including whether a patient requires transfer to a comprehensive stroke center for advanced interventions like mechanical thrombectomy.
Standardizing Stroke Care Across West Virginia
Historically, stroke assessment has been subject to variability, particularly in community hospitals lacking 24/7 on-site neurological expertise. Relying on on-call radiologists, who may not have specialized training in neurovascular imaging, could lead to delays in diagnosis and treatment, or even misdiagnosis. Brainomix 360 Stroke automates much of this process, providing a consistent, objective evaluation regardless of the clinician’s level of experience or the hospital’s location. The platform’s FDA-cleared algorithms instantly analyze scans, flagging potential LVOs, calculating ASPECTS scores (a standardized measure of early ischemic changes), and estimating the size of the ischemic core – the area of brain tissue already irreversibly damaged.
Charles J. Barkey, Vice President of Information Technology for Northern Panhandle WVU Medicine Hospitals, emphasized the health system’s commitment to leveraging technology to improve patient care. “WVU Medicine is committed to advancing patient care through technologies that support clinical decision making and improve the patient experience,” Barkey stated. “As part of this effort, we recently implemented Brainomix’s AI imaging platform across our network to help reduce time to treatment for potentially critical stroke types.”
The Impact on Treatment Pathways
The deployment of Brainomix 360 Stroke is expected to have a significant impact on the entire stroke care pathway within the WVU Health System. By providing rapid, accurate assessments, the platform can help identify patients who are most likely to benefit from mechanical thrombectomy – a minimally invasive procedure to remove blood clots from the brain. According to Brainomix, clinical studies have demonstrated that implementing the platform can increase mechanical thrombectomy rates by over 50%, leading to improved functional independence for stroke survivors.
Beyond accelerating treatment decisions, the platform also streamlines the process of patient transfer. When a patient arrives at a community hospital, the Brainomix analysis provides the receiving comprehensive stroke center with immediate, standardized diagnostic data. This eliminates delays associated with manual image review and ensures that the stroke team is fully prepared to provide the appropriate care upon the patient’s arrival. The seamless data flow also reduces administrative burden, improves coding accuracy, and optimizes revenue cycle management.
Beyond the Clinical Benefits: Enterprise-Wide Value
The benefits of Brainomix 360 Stroke extend beyond the individual patient. For a large, geographically dispersed health system like WVU Medicine, the platform offers significant operational and financial advantages. Fragmented imaging workflows and inconsistent diagnostic assessments can create friction, delay transfers, and lead to suboptimal care. By standardizing the imaging process across all 25 sites, WVU is streamlining logistics, reducing variability, and improving the overall efficiency of its stroke care network.
This standardization is particularly crucial in a hub-and-spoke model, where patients are often transferred from smaller community hospitals to larger, specialized centers. The AI platform ensures that the receiving center has access to the same high-quality diagnostic information, regardless of where the patient originated. This not only improves patient safety but also facilitates more accurate coding and billing, maximizing the health system’s financial performance.
The deployment of Brainomix 360 Stroke also complements existing telestroke services, allowing remote neurologists to provide expert consultations and guidance to clinicians at community hospitals. The AI-powered analysis provides a valuable second opinion, helping to ensure that all patients receive the best possible care, regardless of their location.
Looking Ahead: The Future of AI in Stroke Care
The WVU Health System’s adoption of Brainomix 360 Stroke is part of a broader trend toward the integration of artificial intelligence into healthcare. AI-powered imaging tools have the potential to revolutionize stroke care by improving diagnostic accuracy, accelerating treatment decisions, and expanding access to specialized expertise. As AI technology continues to evolve, we can expect to see even more innovative applications emerge, further transforming the landscape of stroke management.
The success of this implementation will likely serve as a model for other health systems seeking to improve stroke care and reduce disparities in access to treatment. The ability to deliver consistent, high-quality care across a diverse network of hospitals is a major step forward in the fight against stroke, a disease that continues to affect millions of people worldwide.
WVU Health System will continue to monitor the performance of the Brainomix platform and evaluate its impact on patient outcomes. Further research is planned to assess the long-term benefits of the technology and identify opportunities for further optimization. The health system is committed to remaining at the forefront of innovation in stroke care, ensuring that its patients receive the most advanced and effective treatments available.
The next step for WVU Medicine involves ongoing data analysis to assess the platform’s impact on key metrics, including time to treatment, mechanical thrombectomy rates, and patient outcomes. The health system will also be sharing its experiences with other institutions, contributing to the growing body of knowledge surrounding the use of AI in stroke care.
What are your thoughts on the role of AI in improving stroke care? Share your comments below, and please share this article with your network.
Keep reading